Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Oth­er Medic­i­nal Prod­ucts for Hu­man Use

Medicines for which the Paul-Ehrlich-Institut is responsible, but which are not assigned to a particular group of medicines.

Search results 26 to 30 from a total of 30

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Kind of Vac­cine Li­cense Num­ber Li­cense Date Further Information

Uro-Vax­om

lysierte im­mu­nak­tive Frak­tio­nen aus aus­gewählten Es­cherichia-coli-Stäm­men

An­wen­dung bei rezidi­vieren­den und chro­nis­chen Harn­wegsin­fek­tio­nen

OMEDICAMED Unipes­soal Lda

weitere 450a/85 11.12.1987

Uro-Vax­om 6 mg

Im­mun­thera­peu­tikum bei rezi­di­vieren­den Harn­wegs­in­fek­tio­nen

Phar­ma Gerke GmbH

weitere PEI.H.11524.01.1 02.11.2011

Uro-Vax­om 6 mg Hartkapseln

Multi­bac­te­ri­al Lysat

Im­mun­ther­a­peu­tikum bei rezi­di­vieren­den + chro­nis­chen Harn­wegs­in­fek­tio­nen

EU­RIM-PHAR­MA Arzneimit­tel GmbH

weitere PEI.H.11451.01.1 26.07.2010

Uro-Vax­om, 6 mg Hartkapseln

E. coli-Frak­tio­nen

Im­mun­thera­peu­tikum bei rezi­di­vieren­den Harn­wegs­in­fek­tio­nen

Ori­farm GmbH

weitere PEI.H.12062.01.1 16.07.2021

Uro-Vax­om, 6mg, Hartkapseln

Im­mun­ther­a­peu­tikum bei rezi­di­vieren­den Harn­wegs­in­fek­tio­nen

Aba­cus Medicine A/S

, DK

weitere PEI.H.11979.01.1 21.09.2021

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024